Allele is a cell therapy CDMO and the first dedicated provider of cGMP-grade induced pluripotent stem cells (iPSCs). They offer clinical-grade iPSCs, allied technologies, and CDMO services to accelerate immuno-oncology and regenerative medicine programs. With over a decade of experience serving personalized iPSC approaches, Allele produces best-in-class, commercial-ready iPSCs, providing a clean slate for cell therapy development.